Literature DB >> 21823535

Benign transient hyperphosphatasemia in infants and children: a prospective cohort.

Jonathan E Teitelbaum1, Alexandra Laskowski, Frank P Barrows.   

Abstract

A total of 20 children with benign transient hyperphosphatasemia were prospectively evaluated with no additional investigations recommended except repeat serologic evaluation in 2-3 months. The average age of our patients was 2.5 years (range 1 year 2 months-5 years 10 months). The serum levels of alkaline phosphatase averaged 2383 IU/L (range 1013-5700 IU/L). Levels returned to normal within several months. This condition should be recognized by the clinician in order not to put patients through lengthy, expensive and unnecessary investigations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21823535

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  4 in total

1.  Benign transient hyperphosphatasemia in an infant during zinc supplementation.

Authors:  Ayça Bilge Sönmez; İlter Arifoğlu; Ahmet Yıldırım; Filiz Tütüncüler
Journal:  Turk Pediatri Ars       Date:  2018-06-01

Review 2.  Alkaline phosphatase: a potential biomarker for stroke and implications for treatment.

Authors:  Allison L Brichacek; Candice M Brown
Journal:  Metab Brain Dis       Date:  2018-10-04       Impact factor: 3.584

3.  Normal bone turnover in transient hyperphosphatasemia.

Authors:  Stepan Kutilek; Barbora Cervickova; Pavla Bebova; Marie Kmonickova; Vladimir Nemec
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-05-03

4.  A case series of benign transient hyperphosphatasemia from a pediatric endocrinology reference health facility in Turkey.

Authors:  Fatma Dursun; Heves Kirmizibekmez
Journal:  Pan Afr Med J       Date:  2018-07-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.